Wednesday, August 19, 2026

How Will New Regulations Simplify North-South Trade? A Deep Dive into Food Import Procedures

South Korea simplifies import procedures for North Korean food products to enhance inter-Korean trade and ensure food safety standards.

Why South Korea’s UN Participation on North Korean Human Rights Could Change Everything

South Korea's Minister of Unification affirms co-sponsorship of UN resolution on North Korean human rights while maintaining peaceful coexistence policy.

Kim’s ‘Second-in-Command’ Missing From Key Party Leadership List

Choe Ryong-hae is notably absent from North Korea's new leadership, indicating a potential generational shift in the Workers' Party.

Tag: Cenobamate

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us